Inhibition of human immunodeficiency virus type 1 replication by blocking IκB kinase with noraristeromycin

Journal of Biochemistry

Volumn 144, Issue 5, 2008, Pages 581-589

  Asamitsu, Kaori ^a   Yamaguchi, Tsuyoshi ^b   Nakata, Kenji ^a,c   Hibi, Yurina ^a   Victoriano, Ann Florence B ^a   Imai, Kenichi ^a   Onozaki, Kikuo ^c   Kitade, Yukio ^b   Okamoto, Takashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

IKK; NF B; Noraristreromycin; Phosphorylation; Transcription

Indexed keywords

ARISTEROMYCIN; I KAPPA B; I KAPPA B KINASE; I KAPPA B KINASE BETA; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORARISTEROMYCIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; DRUG POTENCY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; VIRUS INHIBITION; VIRUS REPLICATION;

ADENOSINE; ANTI-HIV AGENTS; CELL LINE; ENZYME INHIBITORS; HIV-1; HUMANS; I-KAPPA B KINASE; NF-KAPPA B; TRANSCRIPTIONAL ACTIVATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 55349114757     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn104     Document Type: Article

References (45)

1. Baeuerle, P.A. and Baltimore, D. (1996) NF-κB: ten years after. Cell 87, 13-20
2. Ghosh, S. and Karin, M. (2002) Missing pieces in the NF-κB puzzle. Cell 109(Suppl), S81-S96
3. Okamoto, T., Sanda, T., and Asamitsu, K. (2007) NF-κB signaling and carcinogenesis. Curr. Pharm. Des. 13, 447-462
4. Okamoto, T. (1995) Anti-AIDS Drug Development: Challenge Strategies and Prospects Regulatory Proteins of Human Immunodeficiency Virus and Therapy, pp. 117-127, Harwood Publishers Inc., Chur, Switzerland
5. Hiscott, J., Kwon, H., and Genin, P. (2001) Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Invest. 107, 143-151
6. Williams, S.A., Chen, L.F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., and Greene, W.C. (2004) Prostratin antagonizes HIV latency by activating NF-κB. J. Biol. Chem. 279, 42008-42017
7. Karin, M. and Ben-Neriah, Y. (2000) Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu. Rev. Immunol. 18, 621-663
8. Jiang, X., Takahashi, N., Matsui, N., Tetsuka, T., and Okamoto, T. The NF-κB activation in lymphotoxinβ receptor signaling depends on the phosphorylation of p65 at serine 536. J. Biol. Chem. 278, 919-926.
9. Sakurai, H., Suzuki, S., Kawasaki, N., Nakano, H., Okazaki, T., Chino, A., Doi, T., and Saiki, I. (2003) Tumor necrosis factor-α-induced IKK phosphorylation of NF-κB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 278, 36916-36923
10. Ariga, A., Namekawa, J., Matsumoto, N., Inoue, J., and Umezawa, K. (2002) Inhibition of tumor necrosis factor-α-induced nuclear translocation and activation of NF-κB by dehydroxymethylepoxyquinomicin. J. Biol. Chem. 277, 24625-24630
11. Tanaka, K., Hasegawa, J., Asamitsu, K., and Okamoto, T. (2007) Magnolia ovovata extract and its active component magnolol prevent skin photoaging via inhibition of nuclear factor kappa B. Eur. J. Pharmacol. 22, 212-219
12. Sato, T., Asamitsu, K., Yang, J.P., Takahashi, N., Tetsuka, T., Yoneyama, A., Kanagawa, A., and Okamoto, T. (1998) Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride. AIDS Res. Hum. Retroviruses 14, 293-298.
13. Yang, J.P., Merin, J.P., Nakano, T., Kato, T., Kitade, Y., and Okamoto, T. (1995) Inhibition of the DNA-binding activity of NF-κB by gold compounds in vitro. FEBS Lett. 361, 89-96
14. Yoshida, S., Kato, T., Sakurada, S., Kurono, C., Yang, J.P., Matsui, N., Soji, T., and Okamoto, T. (1999) Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose. Int. Immunol. 11, 151-158
15. Lenz, H.J. (2003) Clinical update: proteasome inhibitors in solid tumors. Cancer Treat Rev. 29(Suppl 1), 41-48
16. Kishore, N., Sommers, C., Mathialagan, S., Guzova, J., Yao, M., Hauser, S., Huynh, K., Bonar, S., Mielke, C., Albee, L., Weier, R., Graneto, M., Hanau, C., Perry, T., and Tripp, C.S. (2003) A selective IKK-2 inhibitor blocks NF-κB-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J. Biol. Chem. 278, 32861-32871
17. Murata, T., Shimada, M., Sakakibara, S., Yoshino, T., Kadono, H., Masuda, T., Shimazaki, M., Shintani, T., Fuchikami, K., Sakai, K., Inbe, H., Takeshita, K., Niki, T., Umeda, M., Bacon, K.B., Ziegelbauer, K.B., and Lowinger, T.B. (2003) Discovery of novel and selective IKK-β serine-threonine protein kinase inhibitors. Part 1. Bioorg. Med. Chem. Lett. 13, 913-918
18. Sanda, T., Iida, S., Ogura, H., Asamitsu, K., Murata, T., Bacon, K.B., Ueda, R., and Okamoto, T. (2005) Growth inhibition of multiple myeloma cells by a novel IκB kinase inhibitor. Clin. Cancer Res. 11, 1974-1982
19. Sanda, T., Asamitsu, K., Ogura, H., Iida, S., Utsunomiya, A., Ueda, R., and Okamoto, T. (2006) Induction of cell death in adult T-cell leukemia cells by a novel IκB kinase inhibitor. Leukemia 20, 590-598
20. Parmely, M.J., Zhou, W.W., Edwards, C.K. III, Borcherding, D.R., Silverstein, R., and Morrison, D.C. (1993) Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 151, 389-396
21. Bradshaw, M., Rutherford, M.S., Hoeper, B.J., McWhinney, C.D., Borcherding, D.R., Schook, L.B., and Edwards, C.K. III (1995) Specific transcriptional inhibition of bone marrow-derived macrophage tumor necrosis factor-alpha gene expression and protein production using novel enantiomeric carbocyclic nucleoside analogues. J. Pharmacol. Exp. Ther. 273, 1506-1518
22. Borcherding, D.R., Peet, N.P., Munson, H.R., Zhang, H., Hoffman, P.F., Bowlin, T.L., and Edwards, C.K. III (1996) Carbocyclic nucleosides as inhibitors of human tumor necrosis factor-α production: effects of the stereoisomers of (3-hydroxycyclopentyl) adenines. J. Med. Chem. 39, 2615-2620
23. Xia, D., Wang, F., and Parmely, M.J. (2000) Inhibition of nuclear factor-κb activation in mouse macrophages and the RAW 264.7 cell line by a synthetic adenyl carbocyclic nucleoside. Biochem. Pharmaco. 60, 717-727
24. Kitade, Y., Kozaki, A., and Miwa, K. (2002) Synthesis of base-modified noraristeromycin derivatives and their inhibitory activity against human and Plasmodium falciparum recombinant S-adenosyl-L-homocysteine hydrolase. Tetrahedron 58, 1271-1277
25. Kitade, Y., Kojima, H., Zulfiqar, F., Kim, H.-S., and Watanabe, Y. (2003) Synthesis of 2-fluoronoraristeromycin and its Inhibitory activity against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase. Bioorg. Med. Chem. Lett. 13, 3963-3965
26. Suhaib, M., Siddiqi, S.M., Oertel, F.P., Chen, X., and Schneller, S.W. (1993) Enantiospecific synthesis of the fluoro and epimeric derivatives of 5′-Noraristeromycin. J. Chem. Soc. Chem. Commun. 8, 707-708
27. Kitade, Y., Kozaki, A., and Yatome, C. (2001) Facile synthesis of 9-[(1′R, 2′S)-2′-hydroxy-3′-oxocyclopenten-1′-yl]- 9-H-adenine possessing inhibitory activity against human recombinant S-adenosyl-L-homocysteine hydrolase. Tetrahedron Lett. 42, 433-435
28. Victoriano, A.F.B., Asamitsu, K., Hibi, Y., Imai, K., Barzaga, N.G., and Okamoto, T. (2006) Inhibition of human immunodeficiency virus type 1 (HIV-1) replication in latently infected cells by a novel IKK inhibitor. (2006) Antimicrob. Agents Chemother. 50, 547-555
29. Fiorentino, L., Stehlik, C., Oliveira, V., Ariza, M.E., Godzik, A., and Reed, J.C. (2002) A novel PAAD-containing protein that modulates NF-κB induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. J. Biol. Chem. 277, 35333-35340
30. Pomerantz, J.L. and Baltimore, D. (2002) Two pathways to NF-κB. Mol. Cell 10, 693-695
31. Okamoto, T. (2006) NF-κB and rheumatic diseases. Endocr. Metab. Immune Disord. Drug Targets 6, 359-372
32. Frelin, C., Imbert, V., Griessinger, E., Loubat, A., Dreano, M., and Peyron, J.F. (2003) AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-α in Jurkat leukemic cells. Oncogene 22, 8187-8194
33. Ogino, S., Tsuruma, K., Uehara, T., and Nomura, Y. (2004) Herbimycin A abrogates nuclear factor-κB activation by interacting preferentially with the IκB kinase beta subunit. Mol. Pharmacol. 65, 1344-1351
34. Burke, J.R., Pattoli, M.A., Gregor, K.R., Brassil, P.J., MacMaster, J.F., McIntyre, K.W., Yang, X., Iotzova, V.S., Clarke, W., Strnad, J., Qiu, Y., and Zusi, F.C. (2003) BMS-345541 is a highly selective inhibitor of IkB kinase that binds at an allosteric site of the enzyme and blocks NF-κB-dependent transcription in mice. J. Biol. Chem. 278, 1450-1456
35. Yin, M.J., Yamamoto, Y., and Gaynor, R.B. (1998) The antiinflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396, 77-80
36. Tanaka, M., Fuentes, M.E., Yamaguchi, K., Durnin, M.H., Dalrymple, S.A., Hardy, K.L., and Goeddel, D.V. (1999) Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKKβ-deficient mice. Immunity 10, 421-429
37. Hu, Y., Baud, V., Delhase, M., Zhang, P., Deerinck, T., Ellisman, M., Johnson, R., and Karin, M. (1999) Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 284, 316-320
38. Takeda, K., Takeuchi, O., Tsujimura, T., Itami, S., Adachi, O., Kawai, T., Sanjo, H., Yoshikawa, K., Terada, N., and Akira, S. (1999) Limb and skin abnormalities in mice lacking IKKα. Science 284, 313-316
39. Anest, V., Hanson, J.L., Cogswell, P.C., Steinbrecher, K.A., Strahl, B.D., and Baldwin, A.S. (2003) A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression. Nature 423, 659-663
40. Yamamoto, Y., Verma, U.N., Prajapati, S., Kwak, Y.T., and Gaynor, R.B. (2003) Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression. Nature 423, 655-659
41. Cao, Y., Bonizzi, G., Seagroves, T.N., Greten, F.R., Johnson, R., Schmidt, E.V., and Karin, M. (2001) IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107, 763-775
42. Claudio, E., Brown, K., Park, S., Wang, H., and Siebenlist, U. (2002) BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3, 958-965
43. Coope, H.J., Atkinson, P.G., Huhse, B., Belich, M., Janzen, J., Holman, M.J., Klaus, G.G., Johnston, L.H., and Ley, S.C. (2002) CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21, 5375-5385
44. Dejardin, E., Droin, N.M., Delhase, M., Haas, E., Cao, Y., Makris, C., Li, Z.W., Karin, M., Ware, C.F., and Green, D.R. (2002) The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity 17, 525-535
45. Hironaka, N., Mochida, K., Mori, N., Maeda, M., Yamamoto, N., and Yamaoka, S. (2004) Tax-independent constitutive IκB kinase activation in adult T-cell leukemia cells. Neoplasia 6, 266-278